424 related articles for article (PubMed ID: 29413506)
1. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review.
Bazan IS; Mensah KA; Rudkovskaia AA; Adonteng-Boateng PK; Herzog EL; Buckley L; Fares WH
Respir Med; 2018 Jan; 134():42-46. PubMed ID: 29413506
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
Cansu DÜ; Korkmaz C
Clin Rheumatol; 2023 Oct; 42(10):2601-2610. PubMed ID: 36396789
[TBL] [Abstract][Full Text] [Related]
3. Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography.
Choi JH; Joo SJ; Kim J
Int J Rheum Dis; 2016 Jan; 19(1):65-73. PubMed ID: 26820839
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.
Rachdi I; Tougorti M; Daoud F; Aydi Z; Zoubeidi H; Ben Dhaou B; Boussema F
Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):221-225. PubMed ID: 30685083
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension in connective tissue diseases: What every CTD specialist should know - but is afraid to ask!
Sanges S; Sobanski V; Lamblin N; Hachulla E; Savale L; Montani D; Launay D
Rev Med Interne; 2024 Jan; 45(1):26-40. PubMed ID: 37925256
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary arterial hypertension in SLE: what do we know?
Prabu A; Gordon C
Lupus; 2013 Oct; 22(12):1274-85. PubMed ID: 24098000
[TBL] [Abstract][Full Text] [Related]
7. Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).
Sobanski V; Launay D; Hachulla E; Humbert M
Curr Rheumatol Rep; 2016 Feb; 18(2):10. PubMed ID: 26841964
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary arterial hypertension in connective tissue disease].
Cottin V
Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S61-72. PubMed ID: 17057632
[TBL] [Abstract][Full Text] [Related]
9. Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.
Coghlan JG; Galiè N; Barberà JA; Frost AE; Ghofrani HA; Hoeper MM; Kuwana M; McLaughlin VV; Peacock AJ; Simonneau G; Vachiéry JL; Blair C; Gillies H; Miller KL; Harris JHN; Langley J; Rubin LJ;
Ann Rheum Dis; 2017 Jul; 76(7):1219-1227. PubMed ID: 28039187
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis.
Lewis C; Sanderson R; Vasilottos N; Zheutlin A; Visovatti S
Heart Fail Clin; 2023 Jan; 19(1):45-54. PubMed ID: 36435572
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus.
Johnson SR; Granton JT
Eur Respir Rev; 2011 Dec; 20(122):277-86. PubMed ID: 22130821
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.
Condliffe R; Kiely DG; Peacock AJ; Corris PA; Gibbs JS; Vrapi F; Das C; Elliot CA; Johnson M; DeSoyza J; Torpy C; Goldsmith K; Hodgkins D; Hughes RJ; Pepke-Zaba J; Coghlan JG
Am J Respir Crit Care Med; 2009 Jan; 179(2):151-7. PubMed ID: 18931333
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
[TBL] [Abstract][Full Text] [Related]
14. An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature.
Sundaram SM; Chung L
Curr Rheumatol Rep; 2018 Feb; 20(2):10. PubMed ID: 29488016
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China.
Zhao J; Wang Q; Liu Y; Tian Z; Guo X; Wang H; Lai J; Huang C; Yang X; Li M; Zeng X
Int J Cardiol; 2017 Jun; 236():432-437. PubMed ID: 28159359
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary arterial hypertension in connective tissue diseases.
Goldberg A
Cardiol Rev; 2010; 18(2):85-8. PubMed ID: 20160534
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.
Alharbi S; Ahmad Z; Bookman AA; Touma Z; Sanchez-Guerrero J; Mitsakakis N; Johnson SR
J Rheumatol; 2018 Oct; 45(10):1406-1410. PubMed ID: 30008448
[TBL] [Abstract][Full Text] [Related]
18. Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension.
Gaine S; Chin K; Coghlan G; Channick R; Di Scala L; Galiè N; Ghofrani HA; Lang IM; McLaughlin V; Preiss R; Rubin LJ; Simonneau G; Sitbon O; Tapson VF; Hoeper MM
Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28818881
[TBL] [Abstract][Full Text] [Related]
19. [Pulmonary arterial hypertension in collagenoses: clinical features, epidemiology, pathogenesis, diagnosis and treatment].
Ahmadi-Simab K; Gross WL
Z Rheumatol; 2006 Jul; 65(4):297-300, 302-5. PubMed ID: 16804698
[TBL] [Abstract][Full Text] [Related]
20. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
Chung L; Liu J; Parsons L; Hassoun PM; McGoon M; Badesch DB; Miller DP; Nicolls MR; Zamanian RT
Chest; 2010 Dec; 138(6):1383-94. PubMed ID: 20507945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
